Connor, Clark & Lunn Investment Management (CC&L)
IRMD icon

Connor, Clark & Lunn Investment Management (CC&L)’s iRadimed IRMD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,982
Closed -$426K – 1648
2025
Q3 		$426K Sell
5,982
-6,197
-51% -$413K ﹤0.01% 1291
2025
Q2 		$728K Sell
12,179
-2,512
-17% -$138K ﹤0.01% 1146
2025
Q1 		$771K Sell
14,691
-1,615
-10% -$90.7K ﹤0.01% 1035
2024
Q4 		$897K Buy
16,306
+2,921
+22% +$154K ﹤0.01% 977
2024
Q3 		$673K Buy
13,385
+4,708
+54% +$217K ﹤0.01% 1007
2024
Q2 		$381K Buy
8,677
+3,743
+76% +$159K ﹤0.01% 1123
2024
Q1 		$217K Buy
4,934
+408
+9% +$18K ﹤0.01% 1378
2023
Q4 		$215K Sell
4,526
-2,162
-32% -$90.9K ﹤0.01% 1249
2023
Q3 		$297K Sell
6,688
-1,665
-20% -$77.4K ﹤0.01% 1146
2023
Q2 		$399K Buy
+8,353
New +$377K ﹤0.01% 1044
2018
Q4 		– Sell
-5,600
Closed -$208K – 993
2018
Q3 		$208K Buy
+5,600
New +$151K ﹤0.01% 848

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s IRMD Position: Q4 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of iRadimed (IRMD) in Q4 2025, closing a stake of 5,982 shares — an estimated $426K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IRMD in Q3 2018 and held it in 11 quarters. The position peaked at $897K in Q4 2024. 217 funds tracked by Wall St. Rank hold IRMD as of Q4 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining iRadimed position as of Q4 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 5,982 iRadimed shares in Q4 2025, an estimated $426K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in iRadimed in Q3 2018 and held it in 11 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s iRadimed position peaked at $897K in Q4 2024.
  • 217 funds tracked by Wall St. Rank held iRadimed as of Q4 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2025, filed 10 Feb 2026.